Experimental Drug Slows Mental Decline in Alzheimers Patients
FRIDAY, July 27, 2018 -- An experimental drug appears to slow mental decline by as much as 30 percent in Alzheimers disease patients, according to research presented at the annual Alzheimers A
Americans Say Editing Babys Genes OK, Up to a Point: Poll
FRIDAY, July 27, 2018 -- Gene editing is no longer just fodder for sci-fi movies. Most Americans believe its OK to tweak a babys DNA under certain circumstances, a new poll finds.
The Pew Resea
FDA Approves Orilissa
FDA Approves Orilissa (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
NORTH CHICAGO, Ill., July 24, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company,
Daily Low-Dose Aspirin May Be Weapon Against Ovarian Cancer
In fact, daily low-dose aspirin -- the type many older women already take to help their hearts -- was tied to a 10 percent reduction in developing ovarian cancer. It was also tied to as much as
Money Matters
FRIDAY, July 20, 2018 -- Money cant buy you love, but it can come between you and your spouse if you dont have open conversations about it.
According to a poll of more than 1,300 Americans, couples who regularly talk about money -- as of
FDA Approves Symtuza
FDA Approves Symtuza (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
TITUSVILLE, N.J, JULY 17, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson toda